Speeding up the control of upstream industrial chain SIG and re-investing Chinese Medicine Industrialization Project

South News reporter Ma Jianzhong's January 28, Sig pharmaceutical Industry officially released its fifth session of the Board of Directors in 2011 the second provisional meeting resolution.　　The resolution said, SIG pharmaceutical industry will not only contribute 300 million yuan to promote Sichuan Langzhong pharmaceutical industry project, but also in Anhui Bozhou to invest in the construction of Chinese herbal pieces and health food standardization and other production projects.　　According to the introduction of SIG pharmaceutical industry, the start of Sichuan Langzhong Pharmaceutical Industry project, will make its production layout more reasonable, at the same time to achieve integrated traditional Chinese medicine industry chain business model, is conducive to ensuring higher gross margin, to avoid industry risks. Public information shows that the sig pharmaceutical industry in 2010 wholly acquired Sichuan Poetic Pharmaceutical Co., Ltd. and Sichuan Boryeong Pharmaceutical Co. The Langzhong medicine industry project is actually the matching project of the above two cases. According to the plan, SIG pharmaceutical industry will invest 300 million yuan in Langzhong investment in the construction of toxic pieces of production and supply base Chinese medicine production projects. The project intends to land about 350 acres, the project is planned to invest in stages, the first construction time is about 12 months.　　The project is all up to the postpartum, the estimated annual sales revenue of about 400 million yuan, annual after-tax profit is expected to reach about 80.43 million yuan. At the same time, SIG pharmaceutical industry also said that its board also considered the adoption of the "on the investment in Bozhou, Anhui Chinese herbal pieces and health food standardization and other production projects of the bill." The project to the postpartum, the annual production of high-grade Chinese herbal pieces and medicinal products about 20,000 tons, is expected to increase sales revenue of about 1.4 billion yuan.